Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001697571 | SCV000719388 | likely benign | not provided | 2021-07-08 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000886974 | SCV001030505 | likely benign | Wilson disease | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002456342 | SCV002614144 | likely benign | Inborn genetic diseases | 2022-04-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000886974 | SCV002800377 | likely benign | Wilson disease | 2021-08-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003962765 | SCV004780172 | likely benign | ATP7B-related condition | 2020-10-05 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |